Cultures of diabetic foot ulcers without clinical signs of infection do not predict outcomes

Diabetes Care

Volumn 37, Issue 10, 2014, Pages 2693-2701

  Gardner, Sue E ^a   Haleem, Ambar ^b   Jao, Ying Ling ^a   Hillis, Stephen L ^b,c,d   Femino, John E ^c   Phisitkul, Phinit ^c   Heilmann, Kristopher P ^b   Lehman, Shannon M ^a   Franciscus, Carrie L ^d  

^a UNIVERSITY OF IOWA COLLEGE OF NURSING   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c UNIVERSITY OF IOWA   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ANAEROBE; ARTICLE; BACTERIAL INFECTION; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; BETA HEMOLYTIC STREPTOCOCCUS; CLINICAL FEATURE; COHORT ANALYSIS; CONTROLLED STUDY; DIABETIC FOOT; DISEASE ASSOCIATION; DISEASE DURATION; ERYTHEMA; FEMALE; FOOT AMPUTATION; FOOT EDEMA; FOOT PAIN; HUMAN; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL DIVERSITY; OSTEOMYELITIS; PATHOGEN LOAD; PREDICTIVE VALUE; PROGNOSIS; PROSPECTIVE STUDY; PROTEOBACTERIA; TREATMENT OUTCOME; ULCER HEALING; AGED; COMPLICATION; CONTRAINDICATIONS; DEBRIDEMENT; DIABETIC NEUROPATHY; FOLLOW UP; FOOT DISEASES; INCIDENCE; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; MIDDLE AGED; PHYSIOLOGY; PROCEDURES; REGRESSION ANALYSIS; WOUND HEALING;

ANTIINFECTIVE AGENT;

ADULT; AGED; ANTI-BACTERIAL AGENTS; COHORT STUDIES; DEBRIDEMENT; DIABETIC FOOT; DIABETIC NEUROPATHIES; FEMALE; FOLLOW-UP STUDIES; FOOT DISEASES; HUMANS; INCIDENCE; MALE; MICROBIOLOGICAL TECHNIQUES; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSPECTIVE STUDIES; REGRESSION ANALYSIS; WOUND HEALING;

EID: 84908179638     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc14-0051     Document Type: Article

References (35)

1. Lipsky BA, Berendt AR, Cornia PB, et al.; Infectious Diseases Society of America. 2012 Infectious Diseases Society of America clinical practice guideline for the diagnosis and treatment of diabetic foot infections. Clin Infect Dis 2012;54:e132-e173.
2. Gardner SE, Hillis SL, Frantz RA. Clinical signs of infection in diabetic foot ulcers with high microbial load. Biol Res Nurs 2009;11: 119-128.
3. Apelqvist J. Diagnostics and treatment of the diabetic foot. Endocrine 2012;41:384-397.
4. Howell-Jones RS, Price PE, Howard AJ, Thomas DW. Antibiotic prescribing for chronic skin wounds in primary care. Wound Repair Regen 2006;14:387-393.
5. Salcido R. What is bioburden? The link to chronic wounds. Adv Skin Wound Care 2007; 20:368.
6. Gardner SE, Frantz RA. Wound bioburden and infection-related complications in diabetic foot ulcers. Biol Res Nurs 2008;10:44-53.
7. Browne AC, Vearncombe M, Sibbald RG. High bacterial load in asymptomatic diabetic patients with neurotrophic ulcers retards wound healing after application of Dermagraft. Ostomy Wound Manage 2001;47:44-49.
8. Xu L, McLennan SV, Lo L, et al. Bacterial load predicts healing rate in neuropathic diabetic foot ulcers. Diabetes Care 2007;30:378-380.
9. Trengove NJ, Stacey MC, McGechie DF, Mata S. Qualitative bacteriology and leg ulcer healing. J Wound Care 1996;5:277-280.
10. Bowler PG, Duerden BI, Armstrong DG. Wound microbiology and associated approaches to wound management. Clin Microbiol Rev 2001;14:244-269.
11. Eleftheriadou I, Tentolouris N, Argiana V, Jude E, Boulton AJ. Methicillin-resistant Staphylococcus aureus in diabetic foot infections. Drugs 2010;70:1785-1797.
12. Tentolouris N, Petrikkos G, Vallianou N, et al. Prevalence of methicillin-resistant Staphylococcus aureus in infected and uninfected diabetic foot ulcers. Clin Microbiol Infect 2006; 12:186-189.
13. Aragón-͆anchez J, Lipsky BA, Ĺazaro-Martínez JL. Gram-negative diabetic foot osteomyelitis: risk factors and clinical presentation. Int J Low Extrem Wounds 2013;12:63-68.
14. Versalovic J. Manual of Clinical Microbiology. Washington, DC, ASM Press, 2011.
15. Mendes RE, Kiyota KA, Monteiro J, et al. Rapid detection and identification of metallobeta- lactamase-encoding genes by multiplex real-time PCR assay and melt curve analysis. J Clin Microbiol 2007;45:544-547.
16. Richter SS, Heilmann KP, Dohrn CL, et al. Activity of ceftaroline and epidemiologic trends in Staphylococcus aureus isolates collected from 43 medical centers in the United States in 2009. Antimicrob Agents Chemother 2011; 55:4154-4160.
17. Margolis DJ, Berlin JA, Strom BL. Intero bserver agreement, sensitivity, and specificity of a "healed" chronic wound. Wound Repair Regen 1996;4:335-338.
18. Gardner SE, Frantz RA, Hillis SL, Blodgett TJ, Femino LM, Lehman SM. Volume measures using a digital image analysis system are reliable in diabetic foot ulcers. Wounds 2012;24: 146-151.
19. Ince P, Game FL, Jeffcoate WJ. Rate of healing of neuropathic ulcers of the foot in diabetes and its relationship to ulcer duration and ulcer area. Diabetes Care 2007;30:660-663.
20. Harrell FE Jr, Califf RM, Pryor DB, Lee KL, Rosati RA. Evaluating the yield of medical tests. JAMA 1982;247:2543-2546.
21. Harrell FE Jr, Lee KL, Mark DB. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med 1996;15:361-387.
22. Katz IA, Harlan A, Miranda-Palma B, et al. A randomized trial of two irremovable off-loading devices in the management of plantar neuropathic diabetic foot ulcers. Diabetes Care 2005;28: 555-559.
23. Lebrun E, Tomic-Canic M, Kirsner RS. The role of surgical debridement in healing of diabetic foot ulcers. Wound Repair Regen 2010;18: 433-438.
24. Margolis DJ, Malay DS, Hoffstad OJ, et al. Prevalence of diabetes, diabetic foot ulcer, and lower extremity amputation among Medicare beneficiaries, 2006 to 2008. Diabetic foot ulcers. In Data Points #1 (prepared by the University of Pennsylvania DEcIDE Center, under Contract No. HHSA29020050041I). Rockville, MD, Agency for Healthcare Research and Quality, February 2011 [AHRQ Publication No. 10(11)-EHC009-EF].
25. Steed DL, Attinger C, Colaizzi T, et al. Guidelines for the treatment of diabetic ulcers. Wound Repair Regen 2006;14:680-692.
26. Galkowska H, Podbielska A, Olszewski WL, et al. Epidemiology and prevalence of methicillinresistant Staphylococcus aureus and Staphylococcus epidermidis in patients with diabetic foot ulcers: focus on the differences between species isolated from individuals with ischemic vs. neuropathic foot ulcers. Diabetes Res Clin Pract 2009;84:187-193.
27. Reiber GE, Vileikyte L, Boyko EJ, et al. Causal pathways for incident lower-extremity ulcers in patients with diabetes from two settings. Diabetes Care 1999;22:157-162.
28. Johnson SW, DrewRH, May DB. Howlong to treat with antibiotics following amputation in patients with diabetic foot infections? Are the 2012 IDSA DFI guidelines reasonable? J Clin Pharm Ther 2013;38:85-88.
29. Wukich DK, Hobizal KB, Brooks MM. Severity of diabetic foot infection and rate of limb salvage. Foot Ankle Int 2013;34:351-358.
30. Widatalla AH, Mahadi SE, Shawer MA, Elsayem HA, Ahmed ME. Implementation of diabetic foot ulcer classification system for research purposes to predict lower extremity amputation. Int J Diabetes Dev Ctries 2009;29:1-5.
31. Lavery LA, Armstrong DG, Murdoch DP, Peters EJ, Lipsky BA. Validation of the Infectious Diseases Society of America's diabetic foot infection classification system. Clin Infect Dis 2007;44:562-565.
32. Gardner SE, Hillis SL, Heilmann K, Segre JA, Grice EA. The neuropathic diabetic foot ulcer micro biome is associated with clinical factors. Diabetes 2013;62:923-930.
33. Bamberg R, Sullivan PK, Conner-Kerr T. Diagnosis of wound infections: Current culturing practices of U.S. wound care professionals. Wounds 2002;14:314-328.
34. Gardner SE, Frantz RA, Saltzman CL, Hillis SL, Park H, Scherubel M. Diagnostic validity of three swab techniques for identifying chronic wound infection.Wound Repair Regen 2006;14:548-557.
35. Han A, Zenilman JM, Melendez JH, et al. The importance of a multifaceted approach to characterizing the microbial flora of chronic wounds. Wound Repair Regen 2011;19:532-541.